证券时报e公司讯，博拓生物(688767)4月19日晚间公告，公司新冠病毒抗原自测试剂近期取得巴西、缅甸的医疗器械注册证书或生产销售许可书。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
